Close Menu

NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission late last week, Waters reported that it has entered into a credit agreement with JP Morgan Chase that provides the company with a five-year unsecured $300 million term loan and a $1.5 billion revolving facility.

The agreement also allows Waters to request increases to the loan and facility by amounts of not less than $25 million, up to a total additional amount of $200 million. However, JP Morgan Chase is not obligated to increase its loan and Waters can bring in additional lenders.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.